Inspection Record

Dr. Reddy's Laboratories Limited — FDA 483 Findings

US FDAInspected 2023-12-08Published 2023-12-28 3 findingsTraining and personnelLaboratory and QC controls

Inspectors Saleem A AkhtarThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Training and personnel

Employees are not given training in the particular operations they perform as part of their function and current good manufacturing practices.

2Laboratory and QC controls

Determinations of conformance to appropriate written specifications for acceptance are deficient for drug products.

3Laboratory and QC controls

Laboratory records are deficient in that they do not include a complete record of all data obtained during testing.

About this record

Extracted automatically from the document US FDA published on 2023-12-28. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2025-09-05 · US FDA · 4 findings2025-07-18 · US FDA · 6 findings2024-09-16 · Health Canada · 4 findings2023-10-27 · US FDA · 9 findings2023-05-29 · Health Canada · 5 findings2021-10-29 · US FDA · 7 findings
Dr. Reddy's Laboratories Limited findings history — including this company's other documents US FDA documents, 2023 Go to Findings search